Integrated management of multidrug-resistant tuberculosis, HIV, and hepatitis B co-infection in Ghana: a case report
Clinical Scorecard: Comprehensive Approach to Managing Co-infection of Multidrug-Resistant Tuberculosis, HIV, and Hepatitis B in Ghana: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Overlapping drug toxicities and limited treatment options complicate management. |
| Target Population | |
| Care Setting | |
Key Highlights
- Patient diagnosed with rifampicin-resistant pulmonary TB and chronic hepatitis B.
- Challenges included drug stockouts and chronic renal impairment.
- Patient completed a 12-month MDR-TB regimen with microbiological cure.
- Ongoing antiretroviral therapy for HIV; hepatitis B and renal disease under monitoring.
Guideline-Based Recommendations
Diagnosis
- Routine screening for HBV among HIV-positive patients is recommended but not widely implemented.
Management
- Integrated management of MDR-TB, HIV, and hepatitis B is essential.
Monitoring & Follow-up
- Clinical monitoring of hepatitis B and renal disease is necessary.
Risks
- Increased risk of treatment failure and adverse drug reactions due to co-infection.
Patient & Prescribing Data
HIV-positive individuals with co-infection of MDR-TB and hepatitis B.
Cost of managing chronic HBV infection is a barrier for many patients.
Clinical Best Practices
- Ensure continuity of care despite drug stockouts.
- Implement multidisciplinary approaches to manage co-infections.
Related Resources & Content
